- Ceapro is pioneering approach with a natural product as a potential anti-inflammatory - Clinical study to be conducted with the...
BBS-Bioactive Bone Substitutes Plc, Investor News, 22 December 2022 at 3.45 p.m. The management team of BBS-Bioactive Bone Substitutes Plc...
MONTRÉAL, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech...
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 22 December 2022 – On 4 November 2022, Novo Nordisk initiated...